103 related articles for article (PubMed ID: 23625552)
1. Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass.
Kant P; Perry SL; Dexter SP; Race AD; Loadman PM; Hull MA
Obesity (Silver Spring); 2014 Jan; 22(1):202-10. PubMed ID: 23625552
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study.
Chouillard EK; Karaa A; Elkhoury M; Greco VJ;
Surg Obes Relat Dis; 2011; 7(4):500-5. PubMed ID: 21459682
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.
Yaghoubian A; Tolan A; Stabile BE; Kaji AH; Belzberg G; Mun E; Zane R
Am Surg; 2012 Dec; 78(12):1325-8. PubMed ID: 23265120
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study.
Coupaye M; Castel B; Sami O; Tuyeras G; Msika S; Ledoux S
Surg Obes Relat Dis; 2015; 11(4):779-84. PubMed ID: 25851775
[TBL] [Abstract][Full Text] [Related]
5. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
[TBL] [Abstract][Full Text] [Related]
6. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.
Sainsbury A; Goodlad RA; Perry SL; Pollard SG; Robins GG; Hull MA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1401-10. PubMed ID: 18559555
[TBL] [Abstract][Full Text] [Related]
7. Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch.
Topart P; Becouarn G; Ritz P
Surg Obes Relat Dis; 2012; 8(3):250-4. PubMed ID: 21803660
[TBL] [Abstract][Full Text] [Related]
8. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study.
Fenske WK; Dubb S; Bueter M; Seyfried F; Patel K; Tam FW; Frankel AH; le Roux CW
Surg Obes Relat Dis; 2013; 9(4):559-68. PubMed ID: 22608055
[TBL] [Abstract][Full Text] [Related]
9. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.
Kant P; Sainsbury A; Reed KR; Pollard SG; Scott N; Clarke AR; Coletta PL; Hull MA
Gut; 2011 Jul; 60(7):893-901. PubMed ID: 21303912
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.
Afshar S; Malcomson F; Kelly SB; Seymour K; Woodcock S; Mathers JC
Obes Surg; 2018 Apr; 28(4):945-954. PubMed ID: 28990150
[TBL] [Abstract][Full Text] [Related]
11. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic omega-loop gastric bypass for the conversion of failed sleeve gastrectomy: early experience.
Moszkowicz D; Rau C; Guenzi M; Zinzindohoué F; Berger A; Chevallier JM
J Visc Surg; 2013 Dec; 150(6):373-8. PubMed ID: 24139677
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.
Iannelli A; Anty R; Schneck AS; Tran A; Gugenheim J
Surgery; 2011 Mar; 149(3):364-70. PubMed ID: 20932542
[TBL] [Abstract][Full Text] [Related]
14. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity.
Carlin AM; Zeni TM; English WJ; Hawasli AA; Genaw JA; Krause KR; Schram JL; Kole KL; Finks JF; Birkmeyer JD; Share D; Birkmeyer NJ;
Ann Surg; 2013 May; 257(5):791-7. PubMed ID: 23470577
[TBL] [Abstract][Full Text] [Related]
15. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.
Bayham BE; Greenway FL; Bellanger DE; O'Neil CE
Diabetes Technol Ther; 2012 Jan; 14(1):30-4. PubMed ID: 21933001
[TBL] [Abstract][Full Text] [Related]
16. Five-year results of sleeve gastrectomy.
Catheline JM; Fysekidis M; Bachner I; Bihan H; Kassem A; Dbouk R; Bdeoui N; Boschetto A; Cohen R
J Visc Surg; 2013 Nov; 150(5):307-12. PubMed ID: 24060743
[TBL] [Abstract][Full Text] [Related]
17. Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.
Yang PJ; Lee WJ; Tseng PH; Lee PH; Lin MT; Yang WS
Surg Obes Relat Dis; 2014; 10(6):1182-7. PubMed ID: 24713521
[TBL] [Abstract][Full Text] [Related]
18. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects.
Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA
Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285
[TBL] [Abstract][Full Text] [Related]
19. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
[TBL] [Abstract][Full Text] [Related]
20. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient.
Regan JP; Inabnet WB; Gagner M; Pomp A
Obes Surg; 2003 Dec; 13(6):861-4. PubMed ID: 14738671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
